Daniel Cervantes (dcerva@yahoo.com) is an assistant principal scientist with ARMGO Pharma, Tarrytown, New York, where he participates in the development of novel small molecules that normalize the function of ryanodine receptor calcium channels in a number of debilitating disorders.
La vita percorre sempre; mentre noi spesso ci diventiamo cose quasi perduti nel mezzo del camin.
[Life keeps going on; in the meantime, we often become things almost lost in the middle of the road].
—Max E. Valentinuzzi
Jeden Tag denke ich unzählige...
Read more
